It has been proposed that whey protein-based breakfast should be considered as a management strategy in patients with T2DM(13–15) due to stimulating insulin secretion and augmenting incretin effect through glucagon-like peptide 1 (GLP-1) secretion(13,16,17). This evidence concerns the gene INS and type 2 diabetes mellitus.